These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Compounding pharmacies: who is in charge? Pergolizzi JV; Labhsetwar S; LeQuang JA Pain Pract; 2013 Mar; 13(3):253-7. PubMed ID: 23350709 [TBL] [Abstract][Full Text] [Related]
25. Battlefront. Michigan hospital at forefront in national fight against outbreak from tainted injections. McKinney M Mod Healthc; 2012 Nov; 42(47):6-7, 16, 1. PubMed ID: 23488176 [TBL] [Abstract][Full Text] [Related]
27. Prescriptions, privacy, and the First Amendment. Curfman GD; Morrissey S; Drazen JM N Engl J Med; 2011 May; 364(21):2053-5. PubMed ID: 21524208 [No Abstract] [Full Text] [Related]
28. The "Lists": What Do They Mean? Voliva J Int J Pharm Compd; 2016; 20(6):477-479. PubMed ID: 28339386 [No Abstract] [Full Text] [Related]
29. Compounding pharmacies: a viable option, or merely a liability? O'Brien D; Cohen I; Kennedy DJ PM R; 2013 Nov; 5(11):974-81. PubMed ID: 24247017 [No Abstract] [Full Text] [Related]
30. Compounding problems and compounding confusion: federal regulation of compounded drug products and the FDAMA circuit split. Boodoo JM Am J Law Med; 2010; 36(1):220-47. PubMed ID: 20481406 [No Abstract] [Full Text] [Related]
32. U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List). Int J Pharm Compd; 2016; 20(6):457-458. PubMed ID: 28339383 [No Abstract] [Full Text] [Related]
33. The drug quality and security act: how will it change pharmacy? Soukup BJ Consult Pharm; 2014; 29(5):352. PubMed ID: 25203978 [No Abstract] [Full Text] [Related]
34. From the Food and Drug Administration. Crawford LM JAMA; 2002 Oct; 288(13):1579. PubMed ID: 12350176 [No Abstract] [Full Text] [Related]
35. Fungal meningitis outbreak. Todd B Am J Nurs; 2013 Feb; 113(2):52-7. PubMed ID: 23358084 [TBL] [Abstract][Full Text] [Related]
36. The Drug Quality and Security Act--mind the gaps. Outterson K N Engl J Med; 2014 Jan; 370(2):97-9. PubMed ID: 24369048 [No Abstract] [Full Text] [Related]
37. Compounding changes. Litigation, legislation among fallout from outbreak. Lee J Mod Healthc; 2013 Sep; 43(39):32-3. PubMed ID: 24199304 [No Abstract] [Full Text] [Related]
38. What gastroenterologists should know about the gray market, herbal remedies, and compounded pharmaceuticals and their regulation by the Food and Drug Administration. Ehrenpreis ED; Kulkarni P; Burke C; Am J Gastroenterol; 2013 May; 108(5):642-6. PubMed ID: 23644956 [No Abstract] [Full Text] [Related]